TMLHE 抗体 (AA 323-372)
Quick Overview for TMLHE 抗体 (AA 323-372) (ABIN6742153)
抗原
See all TMLHE 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 323-372
-
特异性
- Human TMLHE
-
预测反应
- Percent identity by BLAST analysis: Dog, Rabbit (100%) Xenopus (85%).
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide located between aa323-372 of human TMLHE (Q9NVH6, NP_060666). Percent identity by BLAST analysis: Human, Chimpanzee, Gibbon, Monkey, Mouse, Rat, Elephant, Panda, Dog, Bovine, Rabbit, Horse, Opossum, Turkey, Chicken, Platypus (100%), Pig (92%), Zebra finch, Xenopus, Salmon, Zebrafish (85%), Stickleback (84%).
Type of Immunogen: Synthetic peptide -
亚型
- IgG
-
-
anti-Trimethyllysine Hydroxylase, epsilon (TMLHE) (AA 16-376) antibody
TMLHE 适用: 人 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Trimethyllysine Hydroxylase, epsilon (TMLHE) antibodyTMLHE 适用: 人 IF 宿主: 兔 Polyclonal unconjugated
anti-Trimethyllysine Hydroxylase, epsilon (TMLHE) antibody (Biotin)TMLHE 适用: 人 WB, ELISA, IHC, IHC (p) 宿主: 兔 Polyclonal Biotin
anti-Trimethyllysine Hydroxylase, epsilon (TMLHE) antibody (FITC)TMLHE 适用: 人 WB, ELISA, IHC, IHC (p) 宿主: 兔 Polyclonal FITC
anti-Trimethyllysine Hydroxylase, epsilon (TMLHE) antibody (HRP)TMLHE 适用: 人 WB, ELISA, IHC, IHC (p) 宿主: 兔 Polyclonal HRP
anti-Trimethyllysine Hydroxylase, epsilon (TMLHE) antibodyTMLHE 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1.0 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as second antibody. ELISA titer in peptide based assay: 1:1562500. -
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Distilled water
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
